Pacific Radiance (RXS.SI) Earnings Analysis
Pacific Radiance (RXS.SI) next reports earnings on 2026-08-13. Trailing P/E 5.35.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does RXS.SI next report earnings?
| Next earnings date | 2026-08-13 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
RXS.SI earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-28 | 0.00386 SGD | n/a | n/a | n/a |
RXS.SI valuation and analyst view
| Trailing P/E | 5.35 |
|---|---|
| Trailing EPS | 0.01089 SGD |
| Price / book | 0.87 |
| Dividend yield | 2.30% |
| Market cap | 0.11B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Pacific Radiance (RXS.SI)'s next earnings date?
Pacific Radiance is next scheduled to report on 2026-08-13.
Did RXS.SI beat earnings last quarter?
Consensus estimate data was not available for RXS.SI's 2026-02-28 report.
What is RXS.SI's current P/E ratio and EPS?
RXS.SI trades at a trailing P/E of 5.35 on trailing EPS of 0.010891024862214074 SGD.
What do analysts rate RXS.SI?
RXS.SI has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.